News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,195 Results
Type
Article (40003)
Company Profile (271)
Press Release (659921)
Multimedia
Podcasts (50)
Webinars (12)
Section
Business (205050)
Career Advice (2020)
Deals (35527)
Drug Delivery (97)
Drug Development (81225)
Employer Resources (172)
FDA (16198)
Job Trends (14906)
News (346385)
Policy (32633)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2571)
Accelerated approval (5)
Adcomms (20)
Allergies (82)
Alliances (49746)
ALS (86)
Alzheimer's disease (1373)
Antibody-drug conjugate (ADC) (115)
Approvals (16200)
Artificial intelligence (241)
Autoimmune disease (21)
Automation (15)
Bankruptcy (363)
Best Places to Work (11658)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (190)
Bladder cancer (61)
Brain cancer (26)
Breast cancer (263)
Cancer (2090)
Cardiovascular disease (167)
Career advice (1686)
Career pathing (29)
CAR-T (144)
Cell therapy (406)
Cervical cancer (19)
Clinical research (65960)
Collaboration (802)
Compensation (508)
Complete response letters (19)
COVID-19 (2598)
CRISPR (38)
C-suite (224)
Cystic fibrosis (100)
Data (2052)
Decentralized trials (2)
Denatured (19)
Depression (39)
Diabetes (257)
Diagnostics (6369)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (118)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (91)
Earnings (86467)
Editorial (35)
Employer branding (21)
Employer resources (146)
Events (112396)
Executive appointments (699)
FDA (17385)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (724)
Gene editing (102)
Generative AI (19)
Gene therapy (285)
GLP-1 (701)
Government (4419)
Grass and pollen (4)
Guidances (51)
Healthcare (18831)
Huntington's disease (24)
IgA nephropathy (24)
Immunology and inflammation (113)
Indications (26)
Infectious disease (2739)
Inflammatory bowel disease (137)
Inflation Reduction Act (10)
Influenza (50)
Intellectual property (91)
Interviews (311)
IPO (16527)
IRA (42)
Job creations (3663)
Job search strategy (1434)
Kidney cancer (9)
Labor market (36)
Layoffs (466)
Leadership (16)
Legal (7940)
Liver cancer (72)
Lung cancer (302)
Lymphoma (139)
Machine learning (5)
Management (58)
Manufacturing (283)
MASH (62)
Medical device (13356)
Medtech (13361)
Mergers & acquisitions (19514)
Metabolic disorders (657)
Multiple sclerosis (75)
NASH (16)
Neurodegenerative disease (84)
Neuropsychiatric disorders (24)
Neuroscience (1881)
NextGen: Class of 2025 (6548)
Non-profit (4487)
Northern California (2538)
Now hiring (38)
Obesity (353)
Opinion (207)
Ovarian cancer (73)
Pain (81)
Pancreatic cancer (81)
Parkinson's disease (146)
Partnered (21)
Patents (222)
Patient recruitment (99)
Peanut (46)
People (57538)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20563)
Phase II (29051)
Phase III (21638)
Pipeline (1115)
Policy (133)
Postmarket research (2564)
Preclinical (8707)
Press Release (64)
Prostate cancer (98)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (371)
Real estate (5952)
Recruiting (65)
Regulatory (22268)
Reports (46)
Research institute (2326)
Resumes & cover letters (350)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (65)
Series A (127)
Series B (81)
Service/supplier (13)
Sickle cell disease (52)
Southern California (2190)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3625)
State (2)
Stomach cancer (13)
Supply chain (65)
Tariffs (24)
The Weekly (29)
United States (22063)
Vaccines (670)
Venture capitalists (40)
Weight loss (230)
Women's health (34)
Worklife (15)
Date
Last 7 days (471)
Last 30 days (2168)
Last 365 days (32907)
2025 (9237)
2024 (35330)
2023 (40179)
2022 (51287)
2021 (55834)
2020 (54153)
2019 (46641)
2018 (35123)
2017 (32222)
2016 (31629)
2015 (37706)
2014 (31454)
2013 (26499)
2012 (28770)
2011 (29426)
2010 (27525)
Location
Africa (721)
Alabama (52)
Alaska (7)
Arizona (229)
Arkansas (13)
Asia (37962)
Australia (6224)
California (5799)
Canada (1940)
China (490)
Colorado (255)
Connecticut (262)
Delaware (134)
Europe (81523)
Florida (860)
Georgia (202)
Idaho (58)
Illinois (516)
India (26)
Indiana (301)
Iowa (9)
Japan (149)
Kansas (103)
Kentucky (23)
Louisiana (9)
Maine (62)
Maryland (857)
Massachusetts (4345)
Michigan (215)
Minnesota (378)
Mississippi (2)
Missouri (78)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (63)
New Jersey (1661)
New Mexico (28)
New York (1651)
North Carolina (936)
North Dakota (7)
Northern California (2538)
Ohio (196)
Oklahoma (14)
Oregon (34)
Pennsylvania (1307)
Puerto Rico (11)
Rhode Island (30)
South America (1099)
South Carolina (20)
South Dakota (1)
Southern California (2190)
Tennessee (99)
Texas (865)
Utah (171)
Virginia (136)
Washington D.C. (60)
Washington State (533)
West Virginia (3)
Wisconsin (51)
700,195 Results for "bridgene biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Collaboration
Takeda Pumps $770M Into Another BridGene Pact to Hit ‘Undruggable’ Targets
BridGene strikes another partnership with Takeda as the latter company continues its dealmaking streak, following high-ticket agreements with Keros Therapeutics, AC Immune and Degron Therapeutics in the past nine months.
February 25, 2025
·
2 min read
·
Tristan Manalac
Drug Development
BridGene Biosciences Announces Dosing of First Patient in Phase 1 Study Evaluating Novel TEAD Inhibitor BGC515 in Advanced Solid Tumors
BridGene Biosciences, Inc., a leader in developing covalent small molecule drugs for traditional “hard-to-drug” targets, announced today that the first patient has been dosed in its Phase 1 clinical trial of BGC515, a novel TEAD inhibitor discovered through BridGene’s cutting-edge chemoproteomic platform, IMTAC™.
June 28, 2024
·
3 min read
Business
Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncology
Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it has entered into a strategic collaboration and licensing agreement with BridGene Biosciences, Inc. (“Bridgene”), a biotechnology company that uses proprietary chemoproteomics technology to discover novel small molecule drug candidates.
January 3, 2024
·
5 min read
Business
BridGene Biosciences Announces Strategic Collaboration with Galapagos to Discover Small Molecule Drugs for Oncology Targets
BridGene Biosciences, Inc., a leader in the discovery of small molecule drugs for traditional “hard-to-drug” targets, announced today a strategic collaboration and licensing agreement with Galapagos NV (Euronext & NASDAQ: GLPG).
January 3, 2024
·
3 min read
Drug Development
BridGene Biosciences Achieves the Second Preclinical Milestone in Takeda Collaboration
BridGene Biosciences, Inc. announced a significant preclinical milestone in its collaboration with Takeda.
August 28, 2023
·
3 min read
Business
BridGene Biosciences Achieves Milestone in Takeda Collaboration
BridGene Biosciences, Inc. announced that it has achieved a significant milestone in its collaboration with Takeda.
March 8, 2023
·
2 min read
Press Releases
Parse Biosciences Partners with Japanese Distributor, SCRUM Inc.
April 2, 2025
·
2 min read
Biotech Bay
BridGene Biosciences to Present at Hippo Pathway Targeted Drug Development Summit
BridGene Biosciences, Inc. announced that Wolf Wiedemeyer , Ph.D., head of biology at BridGene, will be giving a presentation, titled “A Covalent TEAD Inhibitor with Exceptional Anti-cancer Activity & Combination Potential,” at the 2nd Annual Hippo Pathway Targeted Drug Development Summit on May 24 in Boston.
May 18, 2023
·
2 min read
Press Releases
Xenetic Biosciences, Inc. Releases Virtual Investor “What This Means” Segment
April 10, 2025
·
5 min read
Press Releases
Forte Biosciences, Inc. Announces Results and Provides Clinical Update
March 31, 2025
·
7 min read
1 of 70,020
Next
